Genus PLC (GNS.L)
GNS.L on London Stock Exchange
2,598.00GBp
21 Aug 2019
2,598.00GBp
21 Aug 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
2,598.00
2,598.00
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
77,786
77,786
52-wk High
2,950.94
2,950.94
52-wk Low
2,090.00
2,090.00
About
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and... (more)
Overall
| Beta: | 0.93 |
| Market Cap(Mil.): | £1,720.04 |
| Shares Outstanding(Mil.): | 65.05 |
| Dividend: | 0.09 |
| Yield (%): | -- |
Financials
UPDATE 1-Medical device maker ConvaTec names Genus top boss as CEO
March 25 British medical devices maker ConvaTec Group Plc on Monday named Genus Plc's top boss Karim Bitar as its chief executive officer and said Chairman Christopher Gent would retire from his role.
Medical device maker ConvaTec names Karim Bitar CEO
March 25 British medical devices maker ConvaTec Group Plc on Monday named Genus Plc's top boss Karim Bitar as its chief executive officer and said Chairman Christopher Gent would retire from his role.
ConvaTec to appoint Karim Bitar from Genus as CEO - Sky News
March 24 Catheter and colostomy bag maker ConvaTec Group Plc will on Monday appoint Karim Bitar as the company's chief executive officer, and will announce the departure of its Chairman Christopher Gent, Sky News reported on Sunday.
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates